HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment with glutamine is associated with down-regulation of Toll-like receptor-4 and myeloid differentiation factor 88 expression and decrease in intestinal mucosal injury caused by lipopolysaccharide endotoxaemia in a rat.

Abstract
Recent evidence suggests that lipopolysaccharide (LPS) endotoxaemia in a rat causes significant mucosal injury. Our objective was to determine the effects of glutamine (Gln) on Toll-like receptor 4 (TLR-4), myeloid differentiation factor 88 (Myd88) and tumour necrosis factor (TNF)-alpha receptor-associated factor 6 (TRAF6) expression in intestinal mucosa following LPS endotoxaemia in a rat. For this purpose, male Sprague-Dawley rats were assigned randomly to one of three experimental groups of 10 rats each: (i) control rats underwent intraperitoneal (i.p.) injection of sterile saline once a day; (ii) rats were treated with LPS given i.p. once a day at a dose of 10 mg/kg for 48 h (two doses); and (iii) rats were pretreated with oral Gln given in drinking water (2%) 48 h before and following injection of LPS. Intestinal mucosal parameters, enterocyte proliferation and apoptosis were determined at death. TLR-4 and MyD88 mRNA expression was measured with reverse transcription-polymerase chain reaction (RT-PCR). TLR-4 and MyD88 protein expression were analysed by Western immunoblotting. We observed a statistically significant (P < 0.05) decrease in mucosal weight, mucosal DNA and enterocyte proliferation and a significant increase in enterocyte apoptosis in rat intestine, following LPS administration. These changes were attenuated significantly by dietary Gln. Expression of TLR-4, MyD88 and TRAF6 mRNA in the mucosal ileum was significantly higher in LPS rats versus control rats (P = 0.0006, P = 0.0015, P = 0.03, respectively) as well as TLR-4 and MyD88 protein expression. The administration of Gln reduced significantly the expression of TLR-4, MyD88 and TRAF6 (P = 0.023, P = 0.014, P = 0.035, respectively) mRNA as well as TLR-4 and MyD88 protein expression in ileum compared to LPS animals. We did not find a significant change in the expression of TLR-4, MyD88 or TRAF6 in the jejunum of different groups. We conclude that treatment with Gln was associated with down-regulation of TLR-4, MyD88 and TRAF6 expression and concomitant decrease in intestinal mucosal injury caused by LPS endotoxaemia in a rat.
AuthorsA Kessel, E Toubi, E Pavlotzky, J Mogilner, A G Coran, M Lurie, R Karry, I Sukhotnik
JournalClinical and experimental immunology (Clin Exp Immunol) Vol. 151 Issue 2 Pg. 341-7 (Feb 2008) ISSN: 1365-2249 [Electronic] England
PMID18070149 (Publication Type: Journal Article)
Chemical References
  • Lipopolysaccharides
  • Myeloid Differentiation Factor 88
  • RNA, Messenger
  • TNF Receptor-Associated Factor 6
  • Tlr4 protein, rat
  • Toll-Like Receptor 4
  • Glutamine
Topics
  • Animals
  • Apoptosis (drug effects, immunology)
  • Cell Proliferation (drug effects)
  • Down-Regulation (drug effects)
  • Endotoxemia (drug therapy, immunology, pathology)
  • Glutamine (pharmacology, therapeutic use)
  • Intestinal Mucosa (immunology, pathology)
  • Intestine, Small (immunology, pathology)
  • Lipopolysaccharides (toxicity)
  • Male
  • Myeloid Differentiation Factor 88 (biosynthesis, genetics)
  • RNA, Messenger (genetics)
  • Rats
  • Rats, Sprague-Dawley
  • TNF Receptor-Associated Factor 6 (biosynthesis, genetics)
  • Toll-Like Receptor 4 (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: